skip to main content
React to this bill with an emoji:
Save your position on this bill bill on a six-point scale from strongly oppose to strongly support:

H.R. 3429 (114th): Pro-LIFE Act

The text of the bill below is as of Jul 29, 2015 (Introduced).

I

114th CONGRESS

1st Session

H. R. 3429

IN THE HOUSE OF REPRESENTATIVES

July 29, 2015

(for himself, Mr. Franks of Arizona, Mr. Stewart, Mr. Duffy, Mr. Neugebauer, Mr. Shimkus, Mr. Jones, Mr. Fleischmann, Mr. Marchant, Mr. Gowdy, Mr. Harris, Mr. Babin, Ms. Jenkins of Kansas, Mr. Pearce, Mr. Collins of New York, Mr. Boustany, Mr. Pittenger, Mr. Duncan of South Carolina, Mr. Barton, and Mr. Kelly of Pennsylvania) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend title IV of the Public Health Service Act to prohibit sale or transactions relating to human fetal tissue.

1.

Short title

This Act may be cited as the Prohibiting the Life-Ending Industry of Fetal Organ Exchange Act or the Pro-LIFE Act.

2.

Prohibiting sale or transactions relating to human fetal tissue

Section 498B(e) of the Public Health Service Act (42 U.S.C. 298g–2(e)) is amended by striking paragraph (3) and inserting the following new paragraph:

(3)

The term valuable consideration includes—

(A)

any payment made or debt incurred;

(B)

any gift, honorarium or recognition of value bestowed;

(C)

any price, charge or fee which is waived, forgiven, reduced or indefinitely delayed,

(D)

any loan or debt which is canceled or otherwise forgiven;

(E)

the transfer of any item from one person to another or provision of any service or granting of any opportunity for which a charge is customarily made, without charge or for a reduced charge; and

(F)

any payments associated with the transportation, implantation, processing, preservation, quality control, or storage of human fetal tissue.

.